Class III — Low Risk

Low risk — use of or exposure to this product is not likely to cause adverse health consequences.

BD-Retic-Count Reticulocyte Reagent System Recalled by Becton, Dickinson and Company, BD Biosciences Due to The carton label for one lot of BD...

Date: March 18, 2016
Company: Becton, Dickinson and Company, BD Biosciences
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Becton, Dickinson and Company, BD Biosciences directly.

Affected Products

BD-Retic-Count Reticulocyte Reagent System; Hematology: Used for in vitro diagnostics

Quantity: 205

Why Was This Recalled?

The carton label for one lot of BD Retic-Count Reticulocyte Reagent System had the incorrect storage conditions. The labels on the reagent as well as the Instructions for Use are correct.

Where Was This Sold?

This product was distributed to 10 states: CA, CT, FL, IN, MA, MN, NY, UT, VA, DC

Affected (10 states)Not affected

About Becton, Dickinson and Company, BD Biosciences

Becton, Dickinson and Company, BD Biosciences has 35 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report